Physician

Sean Michael Fahey, M.D.

According to 2025 Medicare claims, Sean Fahey, M.D. (NPI: 1619976479) practices rheumatology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Iredell, NC. This provider's primary affiliated billing organization is PIEDMONT HEALTHCARE, P.A. (NPI: 1912999897; TIN: 561965983) and primary practice location at 28117-8578. Fahey is affiliated with the agilon health Columbus Ohio ACO, Inc. (DBA: Senior Health Connect ACO 1) (ACO ID: D0114), participating under the REACH model.

Fahey's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 467 traditional Medicare patients, billed 121,269 HCPCS/CPT codes, and received $1,605,826 in Medicare payments. The top billing code was 99213 (Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more). Part D data shows 4,970 prescription claims across 766 beneficiaries totaling $2,808,393 in drug costs, led by Rinvoq (Upadacitinib). Open Payments data shows 7 records totaling $126. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,099,962 to $2,808,393. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	470	100,569	$1,411,669
2016	462	84,903	$1,476,106
2017	529	83,827	$1,589,023
2018	583	78,837	$1,712,293
2019	561	85,404	$1,866,217
2020	502	118,006	$1,991,508
2021	523	97,034	$1,781,551
2022	518	121,759	$2,051,754
2023	513	118,243	$1,578,081
2024	467	121,269	$1,605,826

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	420	3,598	$1,099,962
2016	422	3,752	$1,578,443
2017	492	3,875	$1,875,513
2018	565	4,097	$1,844,473
2019	607	4,291	$2,022,613
2020	624	4,510	$2,462,428
2021	633	4,634	$2,567,973
2022	628	4,541	$2,908,035
2023	669	4,640	$2,990,602
2024	766	4,970	$2,808,393

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	249	640	$65
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	275	486	$12
36415	Insertion of needle into vein for collection of blood sample	255	566	$9
86140	Measurement c-reactive protein for detection of infection or inflammation	202	389	$5
85652	Red blood cell sedimentation rate, to detect inflammation, automated	230	537	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rinvoq	Upadacitinib	64	2,280	$488,193
Humira(Cf) Pen	Adalimumab	52	1,736	$421,958
Enbrel Sureclick	Etanercept	36	1,312	$343,960
Humira(Cf)	Adalimumab	23	1,036	$260,511
Xeljanz Xr	Tofacitinib Citrate	31	990	$184,995

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$126	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sean Michael Fahey, M.D.?

Tedicare shows public-source Medicare data for Sean Michael Fahey, M.D. (NPI 1619976479), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sean Michael Fahey, M.D. have ACO affiliation data?

Sean Michael Fahey, M.D. is shown with ACO affiliation data for agilon health Columbus Ohio ACO, Inc. (DBA: Senior Health Connect ACO 1) (REACH, ACO ID D0114).

What billing organization is linked to Sean Michael Fahey, M.D.?

Sean Michael Fahey, M.D. is linked to PIEDMONT HEALTHCARE, P.A. (billing NPI 1912999897) in the available physician profile data.

Does Sean Michael Fahey, M.D. have Open Payments data?

Sean Michael Fahey, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.